SBIR/STTR Research Award
NOVEL ANTI-INFLAMMATORY THERAPY FOR PSORIASIS
Award amount
$112,764Program and phase
SBIR · Phase IAward year
1999Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Not reported
- Recipient company
- Inotek Pharmaceuticals Corporation
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
Not Available The Air Force requires a new simulation Tool to assess the survivability of aircraft and the lethality of weapon systems. The new tool must have a modern programming structure, be freely-distributed, support physics-based algorithms and multiple geometry formats, be HLA and JMASS compliant, and be thoroughly documented and tested. Modifying existing codes to work in an object-oriented framework (i.e., putting object-oriented wrappers around legacy code) would be insufficient in addressing these requirements since issues such as VV&A, portability, and distribution restrictions would still exist. The proposed solution is to develop a framework of open, cross-platform, freely-distributed, object-oriented modules on which to build the foundation for the next-generation vulnerability/lethality code. New Object-oriented Vulnerability Architecture (NOVA) is the acronym given to this concept. Using this approach, legacy codes can be modified to integrate new capabilities of individual modes as they are completed. It is envisioned that a mix of C++ and Java will be exploited in NOVA to combine the raw computational muscle of C++ with the power and flexibility of Java. The objective for this Phase I SBIR topic is the development of a single reusable code module that can be used as a starting point for the NOVA framework.
Technology keywords
Not reported